Jupiter Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.6M Sell
2,697,699
-412,015
-13% -$3.01M 0.07% 273
2026
Q2
$26.4M Hold
3,109,714
– – 0.13% 194
2026
Q1
$16.9M Sell
3,109,714
-750,362
-19% -$4.21M 0.09% 230
2025
Q4
$27M Buy
3,860,076
+2,880,008
+294% +$22.5M 0.22% 132
2025
Q3
$7.58M Buy
+980,068
New +$7.65M 0.07% 242
2023
Q2
– Sell
-89,843
Closed -$2.33M – 564
2023
Q1
$2.33M Buy
+89,843
New +$2.4M 0.03% 285
2021
Q1
– Sell
-13,032
Closed -$2.6M – 661
2020
Q4
$2.6M Sell
13,032
-26,678
-67% -$5.42M 0.03% 393
2020
Q3
$8.7M Buy
+39,710
New +$8.41M 0.09% 231

Other funds holding TDOC

Jupiter Asset Management's TDOC Position: Q3 2026 in Review

Jupiter Asset Management reduced its Teladoc Health (TDOC) stake by 13% in Q3 2026, selling an estimated $3.01M and leaving 2,697,699 shares worth $15.6M. The position accounts for 0.07% of the portfolio, ranked #273.

Jupiter Asset Management first reported a position in TDOC in Q3 2020 and has held it in 8 quarters since. The position peaked at $27M in Q4 2025. 175 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • Jupiter Asset Management held 2,697,699 shares of Teladoc Health worth $15.6M as of Q3 2026.
  • Jupiter Asset Management sold 412,015 Teladoc Health shares in Q3 2026, an estimated $3.01M.
  • Teladoc Health made up 0.07% of Jupiter Asset Management's portfolio in Q3 2026, its #273 holding.
  • Jupiter Asset Management first reported a position in Teladoc Health in Q3 2020 and has held it in 8 quarters since.
  • Jupiter Asset Management's Teladoc Health position peaked at $27M in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Jupiter Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.